Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Laflamme

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Proceedings. AMIA Symposium|December 5, 2002
Usability evaluation of an experimental text summarization system and three search engines: implications for the reengineering of health care interfacesAndre W Kushniruk, Min-Yem Kan, Kathleen McKeown, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 25, 2010
Novel 5-lipoxygenase isoforms affect the biosynthesis of 5-lipoxygenase productsLuc H Boudreau, Jonathan Bertin, Philippe P Robichaud, et al.
Oncotarget|January 12, 2017
Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processesSami Benzina, Annie-Pier Beauregard, Roxann Guerrette, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Proceedings. AMIA Symposium|December 5, 2002
Usability evaluation of an experimental text summarization system and three search engines: implications for the reengineering of health care interfacesAndre W Kushniruk, Min-Yem Kan, Kathleen McKeown, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 25, 2010
Novel 5-lipoxygenase isoforms affect the biosynthesis of 5-lipoxygenase productsLuc H Boudreau, Jonathan Bertin, Philippe P Robichaud, et al.
Oncotarget|January 12, 2017
Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processesSami Benzina, Annie-Pier Beauregard, Roxann Guerrette, et al.
Pageof 2